Abstract
Auroliposome represents a highly effective siRNA delivery platform for in vitro and in vivo application.
Funding Information
  • NIH Office of the Director (CA 213278)
  • NIH Office of the Director (2CA136494)
  • NIH Office of the Director (P30CA225500)

This publication has 40 references indexed in Scilit: